You are here

Veritas Pharma Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
VRT
Market Maker: 
None Assigned
CSE Index: 
Currency: 

Veritas has developed intellectual property and clinical data relating to various cannabis strains and products. It is the Company’s aim to advance the science behind medicinal cannabis, by developing cannabis-based treatments for specific disease conditions. The Company is also focused on investigating opportunities to acquire income-producing assets in the cannabis industry. Moreover, Veritas intends to leverage its management expertise to enter into mergers and acquisitions with suitable cannabis-industry participants, with a view to generating revenue while continuing its research and development opportunities.  

You are here

Veritas Pharma Inc. (VRT)

SEDAR Information

Company Info

Address
c/o 3200 - 650 West Georgia Street
Vancouver, BC V6B 4P7
Canada
Phone
416 918-6785
Email
ir@veritaspharmainc.com
Website
http://www.veritaspharmainc.com
Listing date
Tuesday, August 12, 2014
Transfer Agent
Computershare Investor Services Inc.
Investor Relations
Mr. Peter McFadden
Email
ir@veritaspharmainc.com
Auditor
MNP LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
12,157,398
Reserved for Issuance: 
0

Company Officers

Peter McFadden , CEO
Peter McFadden , CFO

Bulletins

08/02/2019

2019-0216 – Consolidation - Veritas Pharma Inc. (VRT)

Le 8 février/February 2019

Veritas Pharma Inc. has announced a consolidation of its issued and outstanding share capital on the basis of one (1) post-consolidation share for each ten (10) pre-consolidation common shares. 

As a result, the outstanding shares of the company will be reduced to approximately 12,157,399.

Advertisement

Publicité

Latest CSE News

Upcoming Events

08-12_Virtual_Industry_Updates_Whats_Next_for_the_Cannabis_Industry_Imagery_Website

Virtual Industry Updates: What's Next for the Cannabis Industry?

Wednesday, August 12, 2020 -
3:00pm to 4:15pm